Cambridge Investment Research Advisors, Inc. Haleon PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 73,409 shares of HLN stock, worth $761,251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,409
Previous 71,450
2.74%
Holding current value
$761,251
Previous $607,000
0.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HLN
# of Institutions
624Shares Held
422MCall Options Held
165KPut Options Held
26.7K-
Dodge & Cox San Francisco, CA180MShares$1.87 Billion0.94% of portfolio
-
Clearbridge Investments, LLC New York, NY41.8MShares$433 Million0.29% of portfolio
-
Harding Loevner LP Bridgewater, NJ25.6MShares$266 Million1.2% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14MShares$145 Million0.05% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA9.05MShares$93.9 Million0.15% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.9B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...